<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        9-666-20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        HIDRASEC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RACECADOTRIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Granules for oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        16
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Sachet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        31.24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Laboratoires SOPHARTEX" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Laboratoires SOPHARTEX
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Abbott Laboratories GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A07XA04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmacotherapeutic group &ndash; ATC code: A07XA04 (A: digestive system and metabolism)<br />This medicine is an anti-diarrhoeal product.<br />Hidrasec is indicated in addition to oral rehydration for the symptomatic treatment of acute diarrhoea in children</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>If your doctor has told you that your child is intolerant to certain sugars, you should contact him/her before administering this medicine because it contains sucrose..</p><p><strong>Do not administer Hidrasec 30 mg children if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your child is allergic (hypersensitive) to the active substance or any of the other ingredients of this medicine listed in section 6.</p><p><strong>warnings and precautions</strong></p><p>In children, the onset of diarrhoea, i.e. an increase in the number of daily stools, warrants medical attention.<br />This treatment is administered as a supplement to oral rehydration and lifestyle and dietary measures (refer<br />to the dosage, method and/or route of administration, frequency of administration and duration of treatment<br />section as well as the &ldquo;Dietary advice&rdquo; section).<br />You must seek medical advice quickly in the following cases:</p><p>&bull; Diarrhoea comprising more than 6 liquid stools per day or lasting for more than 24 hours, or accompanied by<br />weight loss. Your doctor will decide whether an oral rehydration solute should be prescribed.<br />&bull; Presence of blood or mucus in the stools and if your child&#39;s temperature rises.<br />&bull; In the event of prolonged or uncontrolled vomiting.<br />&bull; Renal or liver impairment (kidney or liver dysfunction).<br />This medicine is not indicated if your child has diarrhoea whilst taking antibiotics.<br />If your doctor has told you that your child is intolerant to certain sugars, contact your doctor before giving this<br />medicine to your child.<br />Cases of hypersensitivity and Quincke&rsquo;s oedema (swelling) have been reported in patients treated with<br />racecadotril (the active substance contained in this medicine). Angioedema of the face, limbs, lips and mucosa,<br />etc., or swelling of the upper airways such as the tongue, glottis and/or larynx may occur at any time during<br />treatment.<br />If you experience any of these adverse effects, stop taking the treatment immediately and contact your doctor.<br />Patients with a history of angioedema (swelling) not related to racecadotril treatment may be at increased risk of<br />developing angioedema.<br />The concomitant use of racecadotril and other medicines may increase the risk of angioedema (see the section<br />&ldquo;Other medicines and Hidrasec 30 mg children, Granules for oral suspension&rdquo;).<br />Skin reactions have been reported following administration of this medicine. These reactions are mostly mild to<br />moderate. In the event of severe skin reactions, racecadotril treatment must be stopped immediately and medical<br />advice should be sought. Racecadotril must not be reintroduced.</p><p><strong>Children and adolescents</strong><br />Not applicable.</p><p><strong>Other medication and Hidrasec 30 mg children</strong></p><p>Tell your doctor or pharmacist if your child is taking, has recently taken or could be taking any other medicine,<br />especially:<br />- An angiotensin converting enzyme inhibitor (e.g.: perindopril or ramipril) to lower blood pressure and<br />help the heart to function properly.<br />- Angiotensin II antagonists (e.g.: candesartan or irbesartan) to treat high blood pressure and heart failure.<br />Tell your doctor or pharmacist if you are giving or have recently given any other medicine to your child,<br />including over-the-counter medicines.</p><p>&nbsp;</p><p><strong>Hidrasec 30 mg, children, granules for oral suspension with food, drink and alcohol</strong></p><p>Not applicable.</p><p>&nbsp;</p><p><strong>Administer Hidrasec 30 mg children with herbal remedies or alternative treatments</strong></p><p>Not applicable.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>&nbsp;</p><p><strong>Pregnancy</strong></p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p>Based on the data available, as a precautionary measure, Racecadotril should be avoided during pregnancy, regardless of trimester.</p><p>&nbsp;</p><p><strong>Breast-feeding</strong></p><p>This medicine must not be administered during breast-feeding given the lack of information on the diffusion of<br />the active substance in human milk.<br />Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Driving and using machines</strong></p><p>Hidrasec 30 mg has no or negligible influence on the ability to drive or use machines.</p><p>&nbsp;</p><p><strong>Important information about a few ingredients of Hidrasec 30 mg children</strong></p><p>Hidrasec 30 mg children contains approximately 3 g of sucrose (source of glucose and fructose) per sachet..</p><p>If your doctor has prescribed more than 2 sachets of Hidrasec 30 mg children, granules for oral suspension per<br />day (equivalent to more than 5 g of sugar), this should be taken into account in your child&#39;s daily allowance if<br />your child is on a low-sugar diet or has diabetes.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Hidrasec 30 mg, children, granules for oral suspension is available as a powder.<br />It can be poured either onto food or into a glass of water or feeding bottle. Stir vigorously and ensure that your<br />child swallows all of the mixture immediately.</p><p>&nbsp;</p><p><strong><u>Dosage</u></strong></p><p>The standard daily dose is calculated according to your child&#39;s body weight, based on 1.5 mg/kg per dose, up<br />to a maximum of three divided daily doses.</p><p>&nbsp;</p><p><strong>In practice:</strong></p><p><u>Number of sachet(s) per dose based on the child&rsquo;s body weight:</u><br />&bull; Approximately 13 to 27 kg: 1 sachet per dose.<br />&bull; Over 27 kg: 2 sachets per dose<u>.</u></p><p>&nbsp;</p><p><strong><u>Method</u><u> </u><u>of</u><u> </u><u>administration</u></strong></p><p>Oral route</p><p>&nbsp;</p><p><strong><u>Dosing frequency</u></strong></p><p>Day 1: the starting dose, then, depending on the time of the first dose, up to a maximum of three<br />divided daily doses, including the initial dose. The doses should preferably be taken at the start of<br />the three main meals.<br />On the following days: three divided daily doses, preferably at the start of the three main meals.</p><p>Not more than three doses may be taken per day.</p><p><strong><u>Duration of treatment</u></strong></p><p>Treatment will be continued up until the first two solid stools have been passed. Do not administer for more than<br />7 days.<br />Always use as directed by your doctor. Consult your doctor or pharmacist if you are not sure.</p><p><strong><u>Dietary advice</u></strong></p><p>This medicine must be used with an oral rehydration solute to offset fluid loss due to diarrhoea. Ask your<br />doctor or pharmacist if you are unsure.<br />For infants, it is essential to follow the instructions for use and the method used to reconstitute the oral<br />rehydration solute which may be prescribed by your doctor. Dietary advice should also be followed.</p><p>&nbsp;</p><p><strong>If you give more Hidrasec 30 mg children than you should:</strong></p><p>Contact your doctor or pharmacist immediately.</p><p>&nbsp;</p><p><strong>If you forget to give Hidrasec 30 mg children:</strong></p><p>Do not give a double dose to make up for a forgotten dose. Continue with the next dose.</p><p>&nbsp;</p><p><strong>If you stop giving Hidrasec 30 mg children:</strong></p><p>Not applicable</p><p>&nbsp;</p><p>Contact your doctor or pharmacist if you have any further questions regarding the use of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicinal product can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>You must stop giving Hidrasec 30 mg children to your child and must consult your doctor immediately if your child experiences any symptoms of angio-oedema such as:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling of the face, tongue or throat;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallowing difficulties;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nettle rash (urticaria) and breathing difficulties.</p><p>&nbsp;</p><p><strong>Uncommon</strong><strong> </strong><strong>side</strong><strong> </strong><strong>effects</strong><strong> </strong>(affecting at least 1 in 1,000 patients but fewer than 1 in 100 patients):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rash and erythema</p><p>&nbsp;</p><p><strong>Frequency Unknown </strong>(cannot be estimated from the available data):</p><p>Polymorphous rash (pinkish lesions on the limbs and in the mouth), oedema of the tongue, lips, eyelids and<br />face, angioedema (sub-cutaneous inflammation affecting various parts of the body), urticaria, erythema<br />nodosum (inflammation in the form of a nodule beneath the skin), papular rash (skin rash in the form of<br />small, hard, pustular lesions), pruritus (itching affecting the entire body), prurigo (skin lesions causing<br />itching).</p><p>&nbsp;</p><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p><strong>Reporting side effects</strong><br />If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not<br />listed in this leaflet. You can also report side effects directly via:</p><p>-National Pharmacovigilance Center (NPC)</p><p><strong>o </strong>Fax: +966-11-205-7662</p><p><strong>o </strong>SFDA Call Center: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: https://ade.sfda.gov.sa</p></td></tr></tbody></table><p><!--[if mso & !supportInlineShapes & supportFields]><v:shape
 id="_x0000_i1025" type="#_x0000_t75" style='width:451.5pt;height:112.8pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span><![endif]--></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp; Keep this medicine out of the reach and sight of children.<br />Do not use this medicine after the expiry date which is stated on the carton after the abbreviation, &ldquo;EXP&rdquo;.<br />The expiry date refers to the last day of that month.<br />Store at temperature below 30&deg;C.<br />Store in the original packaging.<br />Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to<br />throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong><u>The active substance </u></strong>is Racecadotril (30 mg).</p><p><u>The</u><u> </u><u>other</u><u> </u><u>ingredients</u><u> </u><u>are:</u></p><p>sucrose, anhydrous colloidal silica, polyacrylate dispersion 30%, apricot flavouring.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This medicine is available as white oral powder in a single-dose sachet, with the characteristic odour of
apricot.
Boxes of 16.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing</strong><strong> </strong><strong>Authorisation Holder :&nbsp;</strong></p><p>Abbott Laboratories GmbH</p><p>Freundallee 9A</p><p>30173 Hannover, Germany</p><p><strong>Manufacturer :&nbsp;</strong></p><p>Sophartex,</p><p>21 Rue du pressoir</p><p>28500 Vernouillet, France</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                04 / 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">المجموعة العلاجية الدوائية &ndash; رمز التصنيف الكيميائي العلاجي التشريحي.A07XA04 : (A: الجهاز الهضمي والتمثيل الغذائي).</p><p dir="RTL">هذا الدواء هو منتج مضاد للإسهال</p><p dir="RTL">يتم وصف هيدراسيك بالإضافة إلى الأدوية التي تعالج الجفاف عن طريق الفم وذلك لعلاج أعراض الإسهال الحاد عند</p><p>الاطفال&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;إذا كان طبيبك قد أخبرك أنّ طفلك يعاني من عدم تحمل بعض أنواع السكريات، فيجب عليك الاتصال به/بها قبل إعطاء طفلك هذا الدواء لاحتوائه على السكروز&nbsp;</p><p dir="RTL"><strong>لا تقم باستعمال هيدراسيك 30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم&nbsp;:</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;</strong>إذا كان لدى طفلك حساسية ( فرط الحساسية) تجاه المادة الفعالة أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم 6).</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong><strong>:</strong></p><p dir="RTL">عند الاطفال، ظهور الإسهال، أي زيادة في عدد مرات البراز اليومية، مما يستدعي العناية الطبية.&nbsp;</p><p dir="RTL">يتم تناول هذا العلاج بالاضافة الى&nbsp;محاليل معالجة الجفاف التي تؤخذ عن طريق الفم و تدابير الحمية الغذائية ( ارجع قسم الجرعة , طريقة التناول . معدل التناول , ومدة العلاج تحت عنوان ( التعليمات الغذائية )&nbsp;</p><p dir="RTL">يجب عليك طلب المشورة الطبية العاجلة في الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال الذي ينتج عنه أكثر من 6 حالات براز سائل يوميا أو يستمر لأكثر من 24 ساعة، أو مصحوبا بفقدان الوزن. سوف يقرر طبيبك ما إذا كان ينبغي أن يوصف محاليل معالجة الجفاف التي تؤخذ عن طريق الفم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود دم أو مخاط في البراز وإذا ارتفعت درجة حرارة طفلك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في حالة القيء الخارج عن السيطرة أو المستمر لفترات طويلة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القصور الكلوي أو الكبدي (خلل في وظائف الكلى أو الكبد) بسبب نقص المعلومات المتوفرة</p><p dir="RTL">لا يتم وصف هذا الدواء إذا کان طفلك يعاني من الإسهال بعد العلاج بالمضادات الحيوية.</p><p dir="RTL">تم الإبلاغ عن حالات فرط الحساسية وذمة كوينك (تورم) لدى المرضى الذين عولجوا بـراسيكادوتريل (المادة الفعالة الموجودة في هذا الدواء) . قد تحدث وذمة وعائية في الوجه والأطراف والشفتين والغشاء المخاطي وما إلى ذلك، أو تورم في الشعب الهوائية العلوية مثل اللسان و/أو المزمار و/أو الحنجرة في أي وقت أثناء العلاج.</p><p dir="RTL">إذا واجهت أيًا من هذه الآثار الضارة، توقف عن تناول العلاج فورًا واتصل بطبيبك . المرضى الذين لديهم تاريخ من الوذمة الوعائية (التورم) غير المرتبطة بعلاج راسيكادوتريل قد يكونون أكثر عرضة للإصابة بالوذمة الوعائية .&nbsp;</p><p dir="RTL">قد يؤدي الاستخدام المتزامن لراسيكادوتريل مع أدوية أخرى إلى زيادة خطر الوذمة الوعائية (انظر قسم &ldquo;الأدوية الأخرى و هيدراسيك 30ملجم للاطفال ،حبيبات&nbsp;لمعلق عن طريق الفم &rdquo;).</p><p dir="RTL">تم الإبلاغ عن حدوث ردود فعل حساسية جلدية مع تناول هذا الدواء. غالبا ما تكون هذه التفاعلات خفيفة إلى معتدلة. في</p><p dir="RTL">حالة حدوث ردود فعل جلدية شديدة، يجب إيقاف علاج راسيكادوتريل فورًا وطلب المشورة الطبية. لا يجوز إعادة استعمال راسيكادوتريل .</p><p><strong>الأطفال والمراهقون</strong></p><p dir="RTL">غير قابل للتطبيق.</p><p dir="RTL"><strong>تناول أدوية أخرى مع هيدراسيك<sup> </sup>30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم&nbsp;</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كان طفلك يتناول، أو قد تناول مؤخرا أو من الممكن أن يتناول أي دواء آخر، وخاصة:</p><p dir="RTL">&ndash; مثبط الإنزيم المحول للأنجيوتنسين (مثل بيريندوبريل أو راميبريل) لخفض ضغط الدم ومساعدة القلب على أداء وظائفه بشكل صحيح.</p><p dir="RTL">- مضادات الأنجيوتنسين &nbsp;II(مثل: كانديسارتان أو إربيسارتان) لعلاج ارتفاع ضغط الدم وفشل القلب.</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كان طفلك يتناول أو قد تناول مؤخرا أي دواء آخر، بما في ذلك الأدوية التي يتم تناولها دون</p><p dir="RTL">وصفة طبية.</p><p dir="RTL"><strong>تناول هيدراسيك 30 ملجم للرُّضع مع الطعام والشراب</strong> <strong>و</strong><strong> </strong><strong>الكحول</strong></p><p dir="RTL">غير قابل للتطبيق.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية و</strong><strong> </strong><strong>الخصوبة</strong><strong>:</strong></p><p dir="RTL"><strong>الحمل</strong></p><p dir="RTL">اسألي طبيبك أو الصيدلي للحصول على المشورة قبل تناول أي دواء.</p><p dir="RTL">استنادا إلى البيانات المتاحة، وكإجراء وقائي، ينبغي تجنب تناول راسيكادوتريل أثناء الحمل، بغض النظر عن شهور</p><p dir="RTL">الحمل.</p><p dir="RTL"><strong>الرضاعة الطبيعية</strong></p><p dir="RTL">يجب عدم إعطاء هذا الدواء أثناء الرضاعة الطبيعية نظرا لعدم وجود معلومات حول إفراز المادة الفعالة في لبن الأم.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">ليس لهيدراسيك 30 ملجم أي تأثير أو قد يكون له تأثير ضئيل للغاية على القدرة على القيادة أو استخدام الماكينات.</p><p dir="RTL"><strong>يحتوي هيدراسيك 30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم على السكروز </strong></p><p dir="RTL">يحتوي هذا الدواء على حوالي 3جرام من السكروز (مصدر الجلوكوز والفركتوز) &nbsp;لكل كيس.</p><p dir="RTL">إذا كان الطبيب قد وصف أكثر من 2 أكياس من هيدراسيك 30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم<strong>&nbsp;</strong> يوميا (أي ما يعادل أكثر من 5 جرام من</p><p dir="RTL">السكر)، فيجب أن تأخذ هذه الكمية في الاعتبار وذلك في الاستهلاك اليومي لطفلك إذا كان عليه اتباع نظام غذائي</p><p dir="RTL">منخفض السكر أو في حالة مرض السكري<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>طريقة إعطاء </strong><strong>هيدراسيك 30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم&nbsp;</strong></p><p>يتوفر هيدراسيك 30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم على شكل مسحوق .&nbsp;</p><p dir="RTL">يمكن سكبه إما على الطعام أو في كوب من الماء أو زجاجة الرضاعة. حرك بقوة وتأكد من أن طفلك يبتلع كل الخليط على الفور.</p><p dir="RTL"><strong><u>الجرعة</u></strong></p><p dir="RTL">يتم تحديد الجرعة اليومية القياسية وفقا لوزن طفلك، على أساس 1.5 ملجم/كجم لكل جرعة، بحد أقصى ثلاث جرعات موزعة على مدار اليوم.</p><p dir="RTL"><strong>في الممارسة العملية:</strong></p><p dir="RTL"><u>عدد الأكياس لكل جرعة يكون بناءا على وزن الطفل</u><u>:&nbsp;</u></p><p dir="RTL">الأطفال حوالي 13 إلى 27 كجم : 1 كيس لكل جرعة&nbsp;</p><p dir="RTL">الأطفال &nbsp;اكثر من 27 كجم : 2 كيس لكل جرعة&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>طريقة التناول</u></strong></p><p dir="RTL">عن طريق الفم</p><p dir="RTL"><strong>معدل التناول</strong></p><p dir="RTL">اليوم الأول: جرعة البداية، ثم، اعتمادًا على وقت الجرعة الأولى، بحد أقصى ثلاث جرعات يومية مقسمة، بما في ذلك الجرعة الأولية .يفضل أن يتم تناول الجرعات في بداية الوجبات الثلاث الرئيسية.</p><p dir="RTL">في الأيام التالية: ثلاث جرعات يومية مقسمة، ويفضل في بداية الوجبات الثلاث الرئيسية.</p><p dir="RTL">لا يجوز تناول أكثر من ثلاث جرعات في اليوم.</p><p dir="RTL"><strong>مدة العلاج</strong></p><p dir="RTL">يستمر العلاج حتى يتم إخراج أول مرتين من البراز بشكل متماسك. لا يتم التناول لأكثر من 7 أيام.</p><p dir="RTL">يتم التناول دائما وفقا لتوجيهات الطبيب. استشر طبيبك أو الصيدلي إذا لم تكن متأكدا.&nbsp;</p><p dir="RTL"><strong>التعليمات الغذائية</strong></p><p dir="RTL">هذا الدواء يجب أن يستخدم مع محاليل معالجة الجفاف التي تؤخذ عن طريق الفم لتعويض فقدان السوائل بسبب الإسهال.</p><p dir="RTL">اسأل طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL">بالنسبة للرضع، فمن الضروري اتباع تعليمات الاستخدام والطريقة المستخدمة لتحضير محلول معالجة الجفاف التي قد يصفها لك طبيبك. ينبغي أيضا اتباع التعليمات الغذائية.</p><p dir="RTL"><strong>&nbsp;إذا قمت بإعطاء هيدراسيك 30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم&nbsp;&nbsp;أكثر مما يجب:</strong></p><p dir="RTL">اتصل بطبيبك أو الصيدلي فورا.</p><p dir="RTL"><strong>إذا نسيت إعطاء هيدراسيك 30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم&nbsp;</strong></p><p dir="RTL">لا تعطي جرعة مضاعفة للتعويض عن الجرعة المنسية. استمر بإعطاء الجرعة التالية في موعدها.</p><p dir="RTL"><strong>&nbsp;إذا توقفت عن إعطاء هيدراسيك 30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم&nbsp;</strong></p><p dir="RTL">غير قابل للتطبيق</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى بشأن استخدام هذا الدواء فيجب أن تتصل بطبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يتسبب هذا الدواء في آثار جانبية، على الرغم من أنها لا تؤثر في الجميع.</p><p dir="RTL">يجب التوقف عن إعطاء طفلك هيدراسيك 30 ملجم للاطفال , حبيبات لمعلق عن طريق الفم<strong>&nbsp;</strong> ، واستشر الطبيب على الفور إذا ظهرت أي من أعراض الوذمة الوعائية على طفلك مثل:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في الوجه أو اللسان أو الحلق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبات البلع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي (أرتكاريا) وصعوبات في التنفس.</p><p dir="RTL"><strong>آثار جانبية غير شائعة </strong>&nbsp;(قد تصيب على الأقل مريض واحد من كل 1000 مريض ولكن قد تصيب أقل من مريض واحد من كل 100 مريض) :الطفح الجلدي والحمامي.</p><p dir="RTL"><strong>أعراض جانبية غير معلوم معدلاتها </strong>(لا يمكن تحديد معدلاتها من البيانات المتاحة )&nbsp;</p><p dir="RTL">الطفح الجلدي متعدد الأشكال (طفح لونه وردي على الأطراف وفي الفم)، وذمة اللسان والشفتين والجفون والوجه، وذمة</p><p dir="RTL">وعائية (التهاب تحت الجلد يؤثر على أجزاء مختلفة من الجسم)، الأرتكاريا، العقد الحمامية (التهاب على شكل عقد تحت</p><p dir="RTL">الجلد)، طفح جلدي (طفح جلدي صغير، وصلب، وله بثور)، حكة (حكة تؤثر على الجسم كله)، حكة (الطفح الجلدي</p><p dir="RTL">الذي يسبب الحكة).</p><p dir="RTL"><strong>الإبلاغ عن أي آثار جانبية</strong></p><p dir="RTL">إذا أصيب طفلك بأي آثار جانبية ، تحدث إلى طبيبك أو الصيدلي. يتضمن ذلك أي آثار جانبية محتملة غير مذكورة في هذه النشرة. من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL"><!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span dir=LTR></span><span
dir=LTR></span><span dir=LTR><span dir=LTR></span><span dir=LTR></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--></p><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p><strong>للإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المركز الوطني للتيقظ والسلامة الدوائية (</strong><strong>NPC</strong><strong>)</strong></p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فاكس 7662-205-11-966+</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال: 19999</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p></td></tr></tbody></table><p><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:415.3pt;
 height:90pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p><p>&nbsp;</p><p><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:415.3pt;
 height:90pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p><p>&nbsp;</p><p dir="RTL">من خلال الابلاغ عن الاثار الجانبية , يمكنك المساعدة في توفير مزيد من المعلومات حول سلامة هذا الدواء&nbsp;</p><p><!--[if mso & !supportInlineShapes & supportFields]><span
dir=LTR><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:415.3pt;
 height:90pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيدا عن مرأى ومتناول الأطفال.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ&nbsp;انتهاء الصلاحية المدون على العلبة بعد الاختصار EXP ويشير تاريخ انتهاء الصلاحية يشير إلى اليوم</p><p dir="RTL">الأخير من ذلك الشهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;يحفظ داخل العبوة الأصلية.</p><p dir="RTL">لا ينبغي أن يتم التخلص من الأدوية في مياه الصرف الصحي أو عن طريق النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. هذه التدابير تساعد في الحفاظ على البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي راسيكادوتريل 30 ملجم. لكل كيس جرعة واحدة.</p><p dir="RTL">المكونات الأخرى:</p><p>السكروز، السيليكا الغروية اللامائية، بولي اكريلات المساعدة على التشتت 30 ٪، نكهة المشمش</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">هذا الدواء متوفر&nbsp; على شكل ابيض عن طريق الفم في كيس جرعة واحدة برائحة مشمش مميزة،</p><p>&nbsp;تحتوي العبوة على 16 كيس</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>صاحب رخصة التسويق</strong><strong>:</strong></p><p dir="RTL">أبوت لابوراتوريز جي إم بي إتش</p><p dir="RTL">9 إيه فروندالي</p><p dir="RTL">30173 هانوفر</p><p dir="RTL">ألمانيا&nbsp;</p><p dir="RTL"><strong>المُصنِّع</strong><strong>:</strong></p><p dir="RTL">سوفارتيكس</p><p dir="RTL">21 رو دو بريسوار</p><p dir="RTL">28500 فيرنويلت</p><p dir="RTL">فرنسا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            04/2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hidrasec 30 mg children, Granules for oral suspension

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Racecadotril....................................................................................................................... 30 mg
Per pouch.
Excipient with known effect: each pouch contains 2.9 g sucrose.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral powder in pouches
White powder with a characteristic apricot odour.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As a supplement to oral rehydration, symptomatic treatment of acute diarrhoea in children.<br />The amount of rehydration by oral rehydration solute or by intravenous administration should be<br />adjusted depending on the intensity of the diarrhoea and the age, and the particular circumstances of the<br />child (related disorders, etc.).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Oral administration<br />Hidrasec 30 mg is indicated for children weighing 13 kg or more.<br /><u><strong>Posology</strong></u><br />The usual daily posology is established according to body weight, based on 1.5 mg/kg per dose up to a<br />maximum of three divided daily doses.<br />In practice:<br />Number of sachet(s) per dose, depending on the child&rsquo;s body weight:<br />&bull; For a child weighing 13 kg to 27 kg: 1 x 30 mg sachet, 3 times a day<br />&bull; For a child weighing over 27 kg: 2 x 30 mg sachets, 3 times a day.</p><p><u><strong>Method of administration</strong></u>The powder can be added to food or to a glass of water or feed bottle, stirring thoroughly. The child should<br />swallow all of the mixture immediately.<br />Day 1: a starting dose, then, depending on the time of the first dose, up to a maximum of three divided daily<br />doses (including the first dose). Medication should preferably be administered at the beginning of the three<br />main meals.<br />Subsequent days: three divided daily doses, preferably at the beginning of the three main meals. Not more<br />than three doses must be taken per day.&nbsp;</p><p>The treatment is to be continued until there is a return to two consecutive solid stools, but for no more than 7<br />days.<br />Specific populations<br />No studies have been conducted in children suffering from hepatic or renal insufficiency (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment with Hidrasec is only an adjuvant treatment, administered as a supplement to oral rehydration. It<br />does not, under any circumstances, replace the latter. Rehydration must be routinely carried out in<br />infants/children presenting acute diarrhoea to prevent or treat dehydration. It should be adjusted to<br />compensate for the loss of water and electrolytes.<br />The treatment of acute diarrhoea in children is based essentially on correcting water and electrolyte<br />losses using oral rehydration solutes and early reinstatement of feeding. The methods adopted will<br />depend on the child&rsquo;s age and the type of feeding prior to the diarrhoea.<br />Intravenous rehydration should be considered in the case of severe or prolonged diarrhoea, substantial<br />vomiting, or refusal to feed.<br />The presence of blood or pus in the stools accompanied by fever could be indicative of diarrhoea due to<br />invasive pathogens or other disorders. Antibacterial agents with good systemic diffusion should be<br />administered in the case of infectious diarrhoea with clinical signs of an invasive phenomenon.<br />Racecadotril has not been assessed during antibiotic-related diarrhoea. Consequently, racecadotril should not<br />be used in these cases.<br />Due to potentially reduced bioavailability, racecadotril should not be administered in cases of<br />prolonged or uncontrollable vomiting.<br />Renal and hepatic impairment:<br />In the event of renal or hepatic impairment, Hidrasec should not be administered due to the lack of relevant<br />data.<br />Excipients:<br />This medicinal product contains sucrose. It should not be given to patients with fructose intolerance, glucosegalactose<br />malabsorption syndrome or sucrase/isomaltase deficiency (rare hereditary diseases).<br />This medicinal product contains 2.899 g of sucrose per sachet.<br />If more than 5 g of sucrose (source of glucose and fructose) is contained in the daily dose of this<br />medicinal product, this should be taken into consideration in the recommended daily allowance for<br />patients on a low-sugar diet or presenting diabetes.<br />Hypersensitivity:<br />Cutaneous reactions have been reported with the use of this medicinal product. In the majority of cases, these<br />reactions are mild and do not require treatment. In some situations, however, these reactions can be severe&nbsp;and potentially life-threatening. The link associated with the administration of racecadotril cannot be entirely ruled out. If serious skin reactions appear, racecadotril must be discontinued immediately.<br />Cases of hypersensitivity and Quincke&rsquo;s oedema have been reported in patients receiving racecadotril. These<br />events may occur at any time during treatment.<br />Angioedema of the face, extremities, lips and mucosa may appear.<br />Emergency treatment should be administered immediately if the angioedema is associated with an upper<br />respiratory tract obstruction, e.g. in the region of the tongue, glottis, and/or larynx.<br />Racecadotril must be discontinued and the patient placed under close medical supervision, with initiation<br />of appropriate follow-up until symptoms permanently disappear. Racecadotril must not be reintroduced.<br />Bradykinin-mediated angioedema:<br />Racecadotril or certain therapeutic classes are likely to trigger an angioedema-type vascular reaction of the<br />face and neck, resulting from inhibition of bradykinin degradation.<br />Angioedema can sometimes have fatal consequences due to obstruction of the airways. It can occur<br />independently of the concomitant administration of these medicinal products in cases where the patient has<br />had previous exposure to one of the two protagonists. The history of onset of this effect should be<br />investigated and the need for this type of combination therapy assessed.<br />Concomitant administration of racecadotril with certain medicinal products increasing bradykinin levels,<br />especially angiotensin converting enzyme (ACE) inhibitors (e.g. perindopril and ramipril), increases the<br />risk of bradykinin-mediated angioedema (see section 4.5)<br />A rigorous assessment of the benefit/risk ratio is therefore required before introducing racecadotril<br />treatment to patients receiving angiotensin converting enzyme inhibitors (see section 4.5).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Interaction of racecadotril with angiotensin-converting enzyme (ACE) inhibitors.<br />&nbsp;</p><p><strong><u>Association to be avoided:</u></strong><br /><u><strong>Medicinal products, bradykinin and angioedema</strong></u><br />Certain medicinal products or therapeutic classes are likely to trigger an angioedema-type vascular<br />reaction of the face and neck resulting from inhibition of bradykinin degradation. ACE inhibitors<br />(e.g. perindopril and ramipril) are most frequently involved and, to less of an extent, angiotensin II<br />antagonists (e.g.: candesartan, irbesartan), so-called mTORi (mammalian target of rapamaycin<br />inhibitor) immunosuppressants, gliptin class antidiabetic agents, racecadotril, estramustine, sacubitril<br />and alteplase recombinant.<br />Angioedema can sometimes have fatal consequences due to obstruction of the airways. It can occur<br />independently of the concomitant administration of these medicinal products in cases where the patient has<br />had previous exposure to one of the two protagonists. The history of onset of this effect should be<br />investigated and the need for this type of combination therapy assessed.<br /><strong>Association to be avoided (see also section 4.4)</strong><br />+ Other medicinal products posing a risk of bradykinin-mediated angioedema (see the Medicinal<br />products, bradykinin and angioedema section).<br /><strong>Others</strong><br />The concomitant administration of racecadotril with loperamide or nifuroxazide does not modify the<br />kinetic profile of racecadotril.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong><br />Animal studies have not revealed any direct or indirect harmful toxic effect on reproduction. Clinical data on<br />the use of racecadotril during pregnancy is very sparse. Therefore, as a precautionary measure, Hidrasec<br />should be avoided during pregnancy, regardless of trimester<br /><strong>Breastfeeding</strong><br />IGiven the lack of data regarding the diffusion of racecadotril into human milk, and because of its<br />pharmacological properties and the immaturity of the digestive tract in newborns, Hidrasec should not be<br />administered during breast-feeding.<br /><strong>Fertility</strong><br />No effect on fertility has been observed during fertility studies conducted in male and female<br />rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Racecadotril has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical studies conducted on acute diarrhoea have provided safety-in-use data in 860 infants<br />and children treated with racecadotril and 441 treated with placebo.<br />The adverse reactions listed below have been observed more frequently with racecadotril than<br />with placebo during clinical trials, or have been reported during the post-marketing phase.<br />The frequency of adverse reactions has been defined according to the following convention:<br />very common (&gt;1/10), common (&gt;1/100 to &lt;1/10), uncommon (&gt;1/1,000 to &lt;1/100), rare<br />(&gt;1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000), not known (cannot be estimated from the<br />available data).</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:169px">&nbsp;<strong>System organ class</strong></td><td style="width:132px"><strong>Frequency</strong></td><td style="width:198px"><strong>Adverse reaction</strong></td></tr><tr><td style="width:169px">&nbsp;</td><td style="width:132px">Uncommon</td><td style="width:198px">Rash, erythema</td></tr><tr><td style="width:169px">Skin and subcutaneous<br />tissue disorders</td><td style="width:132px">Frequency not known</td><td style="width:198px">Urticaria, angioedema, oedema of the tongue,<br />face, lips and eyelids, erythema multiforme,<br />erythema nodosum, papular<br />rash, pruritus, prurigo</td></tr></tbody></table><p>&nbsp;<p><br /><strong>Reporting of suspected adverse reactions</strong><br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows<br />continued monitoring of the benefit/risk balance of the medicinal product.<br />National Pharmacovigilance Center (NPC)<br />Fax: +966-1-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail:npc.drug@sfda.gov.sa<br />Website:www.sfda.gov.sa/npc</p></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None of the patients presented any adverse reactions in the overdose cases reported to date.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group: INTESTINAL ANTISECRETORYANTIDIARRHOEAL.<br />ATC code: A07XA04. (A: digestive systemand metabolism).</strong>Racecadotril is a prodrug which must be hydrolysed into its active metabolite, thiorphan, which is an<br />inhibitor of enkephalinase, an enzyme of the cellular membrane, present in different tissues including the<br />intestinal epithelium.<br />This enzyme contributes to the hydrolysis of exogenic and endogenic peptides, such as enkephalins.<br />Racecadotril therefore protects enkephalins against enzymatic degradation, thus prolonging their action on the<br />enkephalinergic synapses of the small intestine and reducing hypersecretion.<br />Racecadotril is a pure intestinal anti-secretory substance. It reduces the intestinal hypersecretion of water<br />and electrolytes induced by the cholera toxin or inflammation, without impacting basal secretion. It acts as<br />an anti-diarrhoeal agent without altering intestinal transit time.<br />In two paediatric clinical trials, racecadotril reduced stool weight by 40% and 46%, respectively, within the<br />first 48 hours.<br />A significant reduction in the duration of the diarrhoea and in the need for rehydration was also observed.<br />Individual data from 1,384 boys and girls presenting acute diarrhoea of varying severity and treated as<br />outpatients or hospital inpatients, were collected in a meta-analysis (9 randomised clinical trials, racecadotril<br />versus placebo, as well as the oral rehydration solution).<br />The average age was 12 months (interquartile range: 6 to 39 months).</p><p>A total of 714 patients were less than one year old, and 670 patients were over one year old. Mean weight<br />varied from 7.4 kg to 12.2 kg, depending on the studies. The mean overall duration of the diarrhoea postinclusion<br />was 2.81 days in the placebo group, and 1.75 days in the racecadotril group.<br />Following oral administration, racecadotril continues to display peripheral action, with no effect on the central<br />nervous system.<br />A randomised, cross-over clinical study has shown that racecadotril 100 mg administered at the<br />therapeutic dose (1 capsule) or a higher dose (4 capsules) did not prolong the QT/QTc interval in 56<br />healthy adult volunteers (unlike the effect observed with moxifloxacine, used as a positive control).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u><strong>Absorption:</strong></u><br />Racecadotril is rapidly absorbed following oral administration. Plasma enkephalinase activity occurs after<br />thirty minutes.<br />The bioavailability of racecadotril is not changed by food, but peak activity is delayed by approximately 1.5<br />hours.<br /><u><strong>Distribution:</strong></u><br />Following oral administration of 14C-labelled racecadotril to healthy volunteers, a 200-fold increase in<br />racecadotril concentrations was recorded in the plasma compared to the blood cells, and a 3-fold increase<br />in the plasma versus total blood volume. There is no significant binding to blood cells.<br />In the plasma, the mean apparent volume of distribution of 66.4 L/kg demonstrates moderate distribution of<br />14C in the other tissues.<br />Ninety percent of the active metabolite of racecadotril, tiorfan, (RS)-N-(1-oxo-2-(mercaptomethyl)3-<br />phenylpropyl) glycine, is bound to plasma proteins, mainly albumin.<br />The pharmacokinetic properties of racecadotril do not alter during repeated dosing or in elderly subjects.<br />The extent and duration of action of racecadotril are dose-dependent. Peak concentrations are reached after<br />approximately 2.5 hours, corresponding to 90% inhibition of the enzymatic activity for the dose of 1.5 mg/kg.<br />Plasma enkephalinase activity continues for around 8 hours following the administration of 100 mg.</p><p><u><strong>Biotransformation:</strong></u><br />The biological half-life of racecadotril, determined on the basis of enkephalinase plasma inhibition, is 3 hours.<br />Racecadotril is rapidly hydrolysed into tiorfan (RS)-N-(1-oxo-2-(mercaptomethyl)-3-phenylpropyl) glycine,<br />its active metabolite, which itself transforms into inactive metabolites S-methylthiorphan sulfoxide, S methyl<br />tiorfan, 2-methane sulfinylmethyl propionic acid and 2-methylsulfanylmethyl propionic acid, which are all<br />formed following more than 10% systemic exposure to the parent molecule.<br />Other minor metabolites have also been detected and quantified in the urine and faecal matter.<br />Repeated dosing with racecadotril does not cause accumulation in the body.<br />The in-vitro data show that racecadotril/tiorfan and its four major inactive metabolites do not significantly<br />inhibit cytochrome CYP 3A4 isoforms, 2D6, 2C9, 1A2 and 2C19.</p><p>The in-vitro data show that racecadotril/tiorfan and its four major inactive metabolites do not significantly<br />induce CYP cytochrome isoforms (family 3A, 2A6, 2B6, 2C9/2C19, family 1A, 2E1) and the enzymes which<br />bind to glucuronyl transferase.<br />Racecadotril does not change the protein binding of products which are strongly bound to proteins, such as<br />tolbutamide, warfarin, niflumic acid, digoxin or phenytoin.<br />In patients with hepatic insufficiency (cirrhosis, Child-Pugh B), the metabolite&rsquo;s kinetic profile displays the<br />same Tmax and T1/2 values and lower Cmax (-65 %) and area under the curve (29 %) compared to healthy<br />subjects.<br />In patients with severe renal insufficiency (creatinine clearance between 11 and 39 ml/min), the metabolite&rsquo;s<br />kinetic profile displays a lower Cmax (-49 %) and larger area under the curve (+15 %) and T1/2 compared to<br />healthy volunteers (creatinine clearance &gt; 70 ml/min).<br />The pharmacodynamic results obtained in the paediatric population are similar to those of the adult<br />population, with Cmax being reached 2.5 hours post-dose. There is no accumulation following<br />administration of repeated doses every 8 hours, for 7 days.</p><p><strong><u>Elimination:</u></strong><br />Racecadotril is eliminated via its active and inactive metabolites. Elimination occurs primarily via the kidneys<br />(81.4%) and, to a lesser extent, in the faeces (about 8%). There is no significant elimination via the pulmonary<br />route (less than 1% of the dose).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Four-week chronic toxicity studies conducted in monkeys and dogs, which are beneficial for assessing the<br />duration of treatment in humans, did not highlight any effect at doses of up to 1,250 mg/kg/day and 200<br />mg/kg, which correspond to safety margins of 625 and 62, respectively (in relation to humans).<br />Racecadotril did not prove to be immunotoxic to mice treated for 1 month.<br />Longer exposure (one year) to monkeys revealed generalised infections and reduced antibody response<br />on vaccination (at a dose of 500 mg/kg/day) and no infection/immune suppression at 120 mg/kg/day.<br />Similarly, a few infectious/immune responses were noted in dogs receiving 200 mg/kg/day for 26 weeks.<br />The clinical significance is not known: see section 4.8.<br />No mutagenic or clastogenic effects of racecadotril were observed during standard in-vivo and invitro testing.<br />No carcinogenicity tests were conducted since treatment is administered short term.<br />Reproductive and development toxicity tests (pre-embryonic and fertility development, antenatal and<br />post-natal development, embryo-foetal development studies) have not revealed any racecadotril-specific<br />effect.<br />Other preclinical effects (such as severe anaemia, probably aplastic, increased diuresis, ketonuria and<br />diarrhoea) were observed only after exposure sufficiently exceeding the maximum exposure in humans.<br />Their clinical significance is not known.<br />A toxicity study conducted in young rats did not reveal any evidence of a significant racecadotril related<br />effect at doses up to 160 mg/kg/day, which is 35 times higher than the recommended paediatric dose (e.g.<br />4.5 mg/kg/day).&nbsp;Despite immature renal function in children under 1 year old, higher levels of exposure are not expected in<br />this particular group.<br />No harmful effects on the central nervous system, cardiovascular system or respiratory function have been<br />highlighted in other pharmacology safety studies.<br />In animals, racecadotril potentiates&nbsp;the effect of butyl hyoscine on the intestinal tract and on the<br />anticonvulsant effect of phenytoin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sucrose, Anhydrous colloidal silica, 30% polyacrylate dispersion, apricot flavouring (vanillin, gamma<br />undecalactone, gamma nonalactone, allyl caproate, lemon, neroli, orange, acacia gum, maltodextrin, sorbitol).&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product does not require any special precautions for storage.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>3 g powder in pouches (PE/paper/aluminium); box of 16.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements for disposal.<br />Any unused medicinal product or waste material should be disposed of in accordance with current legislation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Abbott laboratories GmbH
Freundallee 9A
30173 Hannover, Germany
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                04/2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>